Literature DB >> 2540460

D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics.

W F Hood1, R P Compton, J B Monahan.   

Abstract

We have previously shown that D-cycloserine displaces [3H]glycine binding to a recognition site with properties consistent with an N-methyl-D-aspartate (NMDA) receptor modulatory site. Additionally, D-cycloserine positively modulates the NMDA receptor as evidenced by its dose-dependent enhancement of [3H]1-[1-(2-thienyl)cyclohexyl]piperidine ([3H]TCP) binding to the NMDA receptor-coupled ionophore. Further evaluation of this compound indicates that the maximal stimulation of [3H]TCP binding induced by D-cycloserine is lower than that produced by other compounds acting at the NMDA receptor associated glycine modulatory site (glycine and D-serine). Moreover, the stimulation of [3H]TCP binding induced by D-cycloserine in the presence of various fixed concentrations of glycine results in a family of dose-response curves which asymptotically converge to 40-50% of the maximal stimulation induced by glycine alone. These results are consistent with D-cycloserine acting as a partial agonist of the NMDA receptor via its interaction with the coupled glycine modulatory site.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540460     DOI: 10.1016/0304-3940(89)90379-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  84 in total

Review 1.  Pharmacological enhancement of drug cue extinction learning: translational challenges.

Authors:  K M Kantak; B Á Nic Dhonnchadha
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

2.  NMDA receptor regulates migration of newly generated neurons in the adult hippocampus via Disrupted-In-Schizophrenia 1 (DISC1).

Authors:  Takashi Namba; Guo-Li Ming; Hongjun Song; Chikako Waga; Atsushi Enomoto; Kozo Kaibuchi; Shinichi Kohsaka; Shigeo Uchino
Journal:  J Neurochem       Date:  2011-05-19       Impact factor: 5.372

Review 3.  Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.

Authors:  Christine Konradi; Stephan Heckers
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

4.  Treatment of Alzheimer's disease.

Authors:  D M Bowen; P T Francis; A W Procter; A B Young
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-04       Impact factor: 10.154

Review 5.  Pharmacological treatments of cerebellar ataxia.

Authors:  Masafumi Ogawa
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

Review 6.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

7.  The NMDA positive modulator D-cycloserine potentiates the neuroleptic activity of D1 and D2 dopamine receptor blockers in the rat.

Authors:  R Dall'Olio; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain.

Authors:  Alexia E Metz; Hau-Jie Yau; Maria Virginia Centeno; A Vania Apkarian; Marco Martina
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

Review 9.  Glutamate: its role in learning, memory, and the aging brain.

Authors:  W J McEntee; T H Crook
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Chronic dosing with 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, modulates NMDA inhibition of muscarinic-coupled PI hydrolysis in rat cortical slices.

Authors:  K M Boje; S S Lakhman
Journal:  Neurochem Res       Date:  1998-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.